Core Viewpoint - The company, Shaanxi Kanghui Pharmaceutical Co., Ltd., is set to hold an investor performance briefing on June 13, 2025, to discuss its 2024 annual report and Q1 2025 results, allowing for interactive communication with investors [2][3]. Group 1: Meeting Details - The meeting is scheduled for June 13, 2025, from 11:00 AM to 12:00 PM [3]. - It will take place at the Shanghai Stock Exchange Roadshow Center, accessible online [2][3]. - The format of the meeting will be an online interactive session [2][3]. Group 2: Participation Information - Investors can participate online on June 13, 2025, through the Shanghai Stock Exchange Roadshow Center [4]. - Questions can be submitted from June 6 to June 12, 2025, via the Roadshow Center's website or through the company's email [4][5]. - The company will address commonly asked questions during the briefing [4]. Group 3: Attendees - Key attendees will include the company's Chairman and General Manager, Mr. Wang Yanling, the Board Secretary, Ms. Dong Juan, the Chief Financial Officer, Mr. Zou Binze, and Independent Director, Mr. Kang Yuke [3].
陕西康惠制药股份有限公司 关于召开2024年度暨2025年第一季度业绩说明会的公告